BWX Technologies Inc (NYSE:BWXT) stock rose 2.54% (As on February 24, 11:13:20 AM UTC-4, Source: Google Finance) after the company delivered fourth quarter financial results that surpassed analyst expectations and providing a robust outlook for the year ahead. The company’s performance, particularly in its commercial nuclear operations, fueled a positive market reaction following the earnings announcement. Full-year operating cash flow increased 17% to $479.8 million. Capital expenditures also rose, reflecting ongoing investments in capacity expansion, such as the Cambridge manufacturing plant for the commercial nuclear market. The company ended 2025 with backlog of $7.3 billion, up 50% YoY, driven by large multi-year naval propulsion, special materials, and commercial nuclear power awards. Adjusted EBITDA for the quarter reached $147.5 million, up 13% from $130.3 million in the prior year period.
Moreover, the revenue in the Commercial Operations segment nearly doubled year-over-year in Q4, rising 95% to $297.7 million. This growth was attributed to higher field services, fuel, components, and medical sales, as well as contributions from the recent Kinectrics acquisition. The Government Operations segment, while seeing a slight 1% quarterly revenue dip to $589.1 million, grew 8% for the full year. This segment remains the company’s foundation, driven by naval nuclear component production and special materials processing. In 2025, BWX Technologies expanded its service and product offerings through two acquisitions and secured significant high-value awards across both Government and Commercial segments. The company also made targeted investments to enhance its industrial scale and technical capabilities.
BWXT in the fourth quarter of FY25 has reported the adjusted earnings per share of $1.08, beating the analysts’ estimates for the adjusted earnings per share of $0.90. The company had reported the adjusted revenue growth of 18.7 percent to $885.8 million in the fourth quarter of FY25, beating the analysts’ estimates for revenue of $864.4 million.
Additionally, the board declared a quarterly cash dividend of $0.27 per share, payable in March 2026, marking an increase from the previous $0.25 per share.
BWXT expects revenue of approximately $3.75 billion. This compares to the current analyst consensus estimate for 2026 sales of about $3.75 billion. The company initiated non-GAAP EPS guidance in a range of $4.55 to $4.70. The midpoint of this range ($4.63) is above the current analyst EPS estimate of $4.36 for the full year 2026. The company expects adjusted EBITDA to be in the range of $645-$660 million and free cash flow of $305-$320 million, both representing expected year-over-year growth.